News | Radiology Imaging | December 12, 2019

Philips and Regional Medical Center announce $16 M, Long-term Strategic Partnership to Innovate Patient Care

Partnership gives community health system access to same innovative Philips diagnostic imaging solutions of larger networks, bringing quality care closer to home and delivering on the Quadruple Aim

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures.

Philips Azurion is the next generation image-guided therapy platform that allows you to easily and confidently perform procedures with a unique user experience

Philips Azurion is the next generation image-guided therapy platform that allows you to easily and confidently perform procedures with a unique user experience.

An hour outside of Charleston and 45 minutes from Columbia, RMC is the only acute care provider in the area, serving patients across a roughly 2,400-square-mile region of South Carolina.

An hour outside of Charleston and 45 minutes from Columbia, RMC is the only acute care provider in the area, serving patients across a roughly 2,400-square-mile region of South Carolina. 

December 12, 2019 — Philips and the Regional Medical Center (RMC) announced a strategic 5-year partnership agreement worth $16 M to deliver innovative diagnostic imaging solutions for the residents of rural Orangeburg, Calhoun, Bamberg and Barnwell counties in South Carolina. The partnership will also support the expansion of the region’s only stand-alone community hospital, help RMC to standardize its imaging platforms and better integrate workflows and information, allowing for a better view of the patient. As a result, RMC will be better equipped to deliver on the Quadruple Aim: better outcomes, increased efficiency and improved patient and staff experience.

An hour outside of Charleston and 45 minutes from Columbia, RMC is the only acute care provider in the area, serving patients across a roughly 2,400-square-mile region of South Carolina. The healthcare system includes a 286-bed acute care hospital (designated as a Level III Trauma Center), and 24 primary and specialty care practices in Orangeburg, Calhoun, Bamberg and Barnwell counties. Regional Medical Center recently completed construction of a new $8.6 M emergency care facility in the city of Denmark in South Carolina. The 20,500-square-foot RMC Bamberg/Barnwell Emergency Medical Center provides round-the-clock emergency care, including diagnostic imaging, laboratory, observation and emergency transport services.

Long-term strategic partnerships (LSPs) are a growing trend used within hospitals and health systems to better manage the cost and complexity of their technology investments over a defined period of time, while expanding quality access to advanced medical care in order to improve patient outcomes. Philips is a leader in LSPs and the partnership will provide RMC with access to the latest diagnostic imaging solutions, such as the helium-free Ingenia Ambition X system, which can help improve first-time- right diagnosis and perform faster exams. RMC will have access to industry-leading minimally invasive solutions such as the Philips Azurion image-guided therapy platform. Azurion offers a unique operating system that optimizes integration and an intuitive user interface that puts controls at the clinician’s fingertips.

“Delivering truly outstanding care requires our clinical teams to be at the forefront of the latest developments in medicine. Partnering with a health tech leader like Philips ensures our early and ongoing access to leading-edge solutions that can help us deliver the high quality care our communities deserve,” said Charles Williams, president and CEO of Regional Medical Center. “Having access to quality imaging solutions is key to getting to a faster diagnosis and treatment, which will enable us to continue to expand care and ultimately improve patient outcomes.”

Through Philips Medical Capital’s flexible finance plan, long-term strategic partnerships also provide a predictable and stable financial model, while helping take the guesswork out of technology adoption. Its partnership with Philips will allow RMC to not only offer state-of-the-art technology and standardize its diagnostic imaging, but also better integrate imaging data, allowing clinicians to get access to the right patient data for better diagnosis and treatment.

“At Philips, we understand that delivering on the Quadruple Aim is a challenge for all health systems, regardless of size or location,” said Vitor Rocha, chief market leader of Philips North America. “With 1 in 5 Americans living in rural areas, it is important that we work with health systems like Regional Medical Center to bring innovative care closer to home for the communities they serve. Together, we can ensure that patients in more rural counties get the same access to quality care as their big city neighbors.”  

For more information: www.trmchealth.org.

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Typical CT imaging features for COVID-19. Unenhanced, thin-section axial images of the lungs in a 52-year-old man with a positive RT-PCR (A-D) show bilateral, multifocal rounded (asterisks) and peripheral GGO (arrows) with superimposed interlobular septal thickening and visible intralobular lines (“crazy-paving”). Routine screening CT for diagnosis or exclusion of COVID-19 is currently not recommended by most professional organizations or the US Centers for Disease Control and Prevention. Image courtesy of RSNA

News | Coronavirus (COVID-19) | March 26, 2020
March 26, 2020 — The Radiological Society of North America (RSNA
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Representative examples of the attention heatmaps generated using Grad-CAM method for (a) COVID-19, (b) CAP, and (c) Non-Pneumonia. The heatmaps are standard Jet colormap and overlapped on the original image, the red color highlights the activation region associated with the predicted class. COVID-19 = coronavirus disease 2019, CAP = community acquired pneumonia. Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | March 20, 2020
March 20, 2020 — An arti...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Series CT scans in 35-year-old woman with COVID-19 pneumonia. (a) Scan obtained on illness days 1 showed multiple pure ground-glass opacity (GGO) mainly in right lower lobe. (b) Scan obtained on illness days 5 showed increased extent of GGO and early consolidation. (c) Scan obtained on illness days 11 showed multiple consolidation with almost the same extent. (d) Scan obtained on illness days 15 showed a mixed pattern with a slightly smaller extent, and the perilobular consolidation might suggest the presence of organizing pneumonia. The patient was discharged on illness days 17. Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | March 20, 2020
March 20, 2020 — In a new study pub
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SBI20

Image courtesy of Getty Images

News | Coronavirus (COVID-19) | March 17, 2020
March 17, 2020 — The journal Radiology ...
The low-dose chest computed tomography (CT) scans used in lung cancer screening do not appear to damage human DNA

Immunofluorescent staining performed to depict γ-H2AX foci. Representative images of γ-H2AX foci in peripheral blood lymphocytes in an 82-year-old woman who underwent standard-dose CT. (a) Nuclear DNA of four lymphocytes. (b) γ-H2AX foci (arrows). (c) Markers of DNA double-strand breaks. In this merged image, DNA is blue and γ-H2AX foci are red (arrows show small foci). γ-H2AX, a marker of DNA double-strand breaks, is a phosphorylated type of histone H2AX. Scale bar: 5 mm. Image courtesy of the Radiological Society of North America

News | Lung Cancer | March 11, 2020
March 11, 2020 — The low-dose chest computed tomog...
DBT, sometimes called 3-D mammography, emerged in the last decade as a powerful tool for breast cancer screening

Images in a 57-year-old woman noted to have "good prognosis" invasive cancer detected at digital breast tomosynthesis (DBT) screening. (a) Craniocaudal view of the left breast obtained with the two-dimensional digital mammography (DM) portion of the DM/DBT screening study demonstrates a subtle area of distortion in the medial left breast. (b) Single-slice image from the left craniocaudal DBT portion of the screening study shows an area of bridging distortion (circle). (c) Electronically enlarged image of the area of concern seen on the left craniocaudal view in a single DBT slice as shown in b. (d) Targeted US scan demonstrates two small adjacent irregular solid masses. US-guided core biopsy yielded an invasive carcinoma of the tubular subtype that was estrogen receptor positive, progesterone receptor positive, and human epidermal growth factor receptor 2 negative. The results of the sentinel node biopsy were negative. Image courtesy of the Radiological Society of North America

News | Breast Imaging | March 11, 2020
March 11, 2020 — A new study published in the journal ...
Sponsored Content | Videos | Artificial Intelligence | February 21, 2020
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intel
Sponsored Content | Videos | Enterprise Imaging | February 21, 2020
In Enterprise Imaging at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overvie
Chest CT imaging of patient. #coronavirus #nCoV2019 #2019nCoV #COVID19

Examples of typical chest CT findings compatible with COVID-19 pneumonia in patients with epidemiological and clinical presentation suspicious for COVID-19 infection. This image is part of the original research, Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR, published Feb. 19, 2020, in Radiology Online.

News | Computed Tomography (CT) | February 19, 2020
February 19, 2020 — In new research